&

Showing posts with label Stryker lawsuit. Show all posts
Showing posts with label Stryker lawsuit. Show all posts

Tuesday, January 15, 2013

The Stryker Orthopedics PER Letter: Why All Rejuvenate and ABGII Hip Implant Recipients Should be Cautious



  If you are the recipient of a Stryker Rejuvenate or ABGII hip implant then perhaps you have experienced problems related to the implant. Like other metal-on-metal hip implants, the Rejuvenate and ABGII have the potential of causing metallosis even though the design calls for a ceramic head rather than a metal one. Stryker issued a recall of the both implants this past July, 2012 after first issuing an Urgent Field Safety Notice to hospitals and physicians in the prior April. This notice cited the potential of fretting and corrosion at the neck juncture as well as the risk of metal ion release.

While there is not the same level of surface area as the all-metal implants, the corrosion which can occur in the Stryker Rejuvenate and Stryker ABGII can nonetheless lead to metallosis. In addition to the neck juncture which can result in corrosion, there are metal trunnions located at either end of the neck which allow the component to snap into the stem on one end and the acetabular cup on the other. Body fluids can become trapped under these trunnions, leading to further corrosion. 

Wednesday, November 21, 2012

Why Diagnosing Problems in Stryker Rejuvenate Hip Implants is So Difficult


When the Stryker Rejuvenate and ABGII were recalled in July of 2012, citing potential risk of fretting and corrosion at the neck juncture, many of the implants had already been removed during revision surgeries. Unfortunately, since most physicians were unaware of the problems with the implants, the operative reports were unlikely to list this corrosion. In other words, since the doctors hadn’t been told what issues to look for, there were few records stating that corrosion was a factor in the revision surgery. When Stryker originally told hospitals and surgeons (in an Urgent Field Safety Report in April of 2012) that there could be corrosion or fretting and release of metal ions, there was still no mention of that corrosion occurring anywhere except at the neck juncture.

Tuesday, November 20, 2012

Sales Dip for Stryker Following Hip Implant Recalls


Stryker sales have shown a definite dip in the quart since the recall of the Stryker Rejuvenate and ABGII hip implants in July. The hip implant recall came just months after Stryker issued an Urgent Field Safety Notice to hospitals and physicians in April of 2012 citing the potential of fretting and corrosion at the neck juncture as well as the risk of metal ion release. Stryker’s hip implant sales dropped nearly 10 percent while its knee implant sales dropped 4.3 percent.

Why the Dip in Revenues?

A Stryker company official stated the recalls of the Rejuvenate and ABGII had only a “modest impact” on the company’s third quarter drop in sales. While the recalls certainly would have impacted Stryker’s revenues, the overall economy may also have played a part. Joint replacement surgical procedures are considered elective most of the time. Those with insurance may delay the surgery to avoid missing work while those without insurance likely cannot afford the procedure. Stryker’s CFO, Curt Hartman also stepped down after two decades at the helm. He reportedly received a 1.5 million dollar separation package although he will remain as an adviser to Stryker through February, 2013.

New Design an Improvement Over Metal-on-Metal Implants?

Metal-on-metal hip implants have been responsible for scores of side effects among recipients. The Rejuvenate garnered FDA approval in 2008 and the ABGII in 2009 and were believed to be not only safer than the all-metal implants but the design was innovative in that the stem and neck were separate parts and were manufactured in a variety of sizes. The surgeon could choose the best size according to the size and activity level of the patient. Because the ball of the Stryker models was ceramic and plastic lined the acetabular cup, it was assumed there would be no metal-on-metal parts rubbing against one another, resulting in metal ions shearing away into the body.

Risk of Metal Ion Release

Unfortunately, the neck portion of the Stryker Rejuvenate is made of cobalt and chromium and even though the ball is ceramic, there is a metal intersection as well as metal trundles at both ends of the neck portion. Body fluids trapped in the trundles can lead to corrosion and the metal intersections can also corrode, sending metal ions into the surrounding tissues or the bloodstream. Although the levels of metal ions in the bloodstream from the Rejuvenate may not reach the level of the all-metal implants, any metal in the body can cause issues for the patient. Those patients who are extremely active have an even greater risk of metallosis, leading to pain, necrosis, infection and failure of the implant. While Stryker’s sales may have taken a dip, it is likely that they will soon have bigger problems as eight lawsuits have already been filed following the Rejuvenate and ABGII hip implant recalls. 

Monday, November 19, 2012

Consolidation of Stryker Rejuvenate Hip Lawsuits Placed in New Jersey


The state of New Jersey is expected to consolidate at least ten StrykerRejuvenate and ABGII hip implant lawsuits before one judge in order to expedite the handling of these cases. Multi-district and multi-county litigation is described by Class Action Litigation website as a procedure utilized by federal and state courts to transfer all pending cases which are very similar in nature before one judge. This procedure allows lawsuits to move in a more expeditious manner through the discovery phase while still allowing the injured party to seek an individual trial and have their settlement adjusted based on the degree of injury. This is unlike class action lawsuits which dictate that all members share equally in the settlement even though it is unlikely that all injuries would be equal. The first ten cases are coming from Florida, Minnesota, New Jersey and Arizona. Hackensack, NJ was chosen as the consolidation point because it is close to Stryker headquarters. 

Wednesday, October 17, 2012

Preserving Your Right to a Stryker Hip Implant Lawsuit



If you or a loved one is the recipient of a Stryker ABGII or Stryker Rejuvenate hip implant device it is very important that you preserve your health, your future and your right to recovery. Between the time the devices received approval and hit the market (June 2008 and November, 2009) Stryker received reports of health and safety risks regarding the Rejuvenate and the ABGII. Surgeons across the United States submitted reports which voiced concern for the amount of corrosion and fretting seen in the devices which had been removed from their patients, with one surgeon stating it looked like “black rust” around the modular neck junction.

The April 2012 Urgent Safety Bulletin

In a safety bulletin sent to surgeons and hospitals in April of 2012, Stryker noted that excessive metal debris and ion generation were commonly seen in these Stryker hip implant models. Further, high levels of corrosion and fretting were resulting from the metal ion generation, leading to early failure of the device and the necessity of revision surgery. In this safety bulletin Stryker noted that a certain ph level in some patients caused them to be at a greater risk of harm. Further, they stated that tapers which were not adequately locked or sufficiently cleaned could lead to an increase in metal debris generation.

How the Rejuvenate and ABGII Gained FDA Approval 

Both the Stryker Rejuvenate and the ABGII received FDA approval through a process known as the 510(k). This process allows medical devices and drugs to skip clinical trials by asserting they are substantially similar to a device or drug which has already been approved. Of course the drug or device they are claiming to be similar to could have gained approval in the same way. In this particular case, the Wright Profemur was the device the Rejuvenate claimed to be substantially similar to, and the Profemur has had its share of adverse events among its recipients as well. This process causes unsuspecting patients to become guinea pigs as the manufacturer really has no idea whether or not the device or drug is truly safe. Most of us expect that our surgeons will not implant an unsafe device into our bodies, and most surgeons expect that an FDA approved device or drug can be considered safe. Unfortunately this is not always the case, and the metal-on-metal hip implants have had more than their share of troubles.

Don’t Lose Your Right to File a Claim against Stryker

It is believed that over half a million Americans currently have a metal-on-metal hip implant in their body which is, in some ways, akin to a ticking time bomb. When the metal ions shear away from the device they become lodged in the surrounding tissue and cause pain and inflammation or they make their way to the bloodstream where they can eventually cause metal toxicity. The symptoms of metal toxicity may lay dormant for as long as several years and if the patient has not preserved his or her right to recovery—by speaking to an experienced Stryker hip recall attorney—they could find themselves with damaged health and a mountain of medical bills following revision surgery.

Monday, October 15, 2012

Safety Warnings Regarding Stryker Rejuvenate and ABGII



Just this last April Stryker Orthopedics issued a safety bulletin to doctors and hospitals regarding two hip implants, the Rejuvenate and the ABGII. The bulletin listed the potential for excessive metal debris and metal ion generation in these hip implants, stating this could lead to extreme levels of fretting and corrosion of the hip implant. When fretting and corrosion occur in hip implants, the patient will usually have to undergo revision surgery which is both risky and complex. Additionally, when the metal ions which have been generated from the hip implant shear away from the device, they may either become lodged in the surrounding tissues or can enter the bloodstream. Either of these can cause serious health issues for the implant recipient.

Other Issues Related to the Safety Bulletin
Further, patients who have a heightened sensitivity to these metal ions could have an allergic reaction which causes the tissue surrounding the hip to become inflamed and painful. Stryker listed certain factors which could increase the risk of the metal ions including femoral offset, ph factors of the individual, excess weight of the implant recipient and patient diabetes or infection. When the femoral has too much offset, there will be greater bending motions at the taper junction as well as between the neck and stem.

Saturday, October 13, 2012

Is Your Safety Being Ignored in the Approval of Medical Devices and Drugs?



While the FDA declined to require Stryker, a Michigan-based manufacture of medical devices, to recall their Rejuvenate and ABGII hip implants the company made the decision to issue a voluntary recall this past July. The recall came on the heels of an Urgent Field Safety Notice sent out to surgeons and hospitals in April of 2012. That safety notice acknowledged the possibility of metal toxicity from the hip implants admitting to corrosion and wear at the junction of the metal implants.

Adverse Health Effects from Metal Toxicity
Any time two metal surfaces come into contact with one another, corrosion can occur in the form of tiny metal shards shearing away from the implant and lodging in nearby hip tissue or entering into the bloodstream. Extreme inflammation, chronic and severe pain and destruction or death of the tissue can result from those tiny metal ions. Should the metal shards enter into the bloodstream, metal toxicity can occur. Every person will respond differently to varying levels of toxic metals in the body—while some people may have serious adverse reactions to relatively small amounts of metals in the body, others may not have any overt reactions until the levels are extremely high.

Monday, October 8, 2012

Stryker Rejuvenate and ABGII—Getting the Legal Help You Need



A short time after the FDA approved the Stryker Rejuvenate metal hip implant in June of 2008, adverse reports from recipients of the implant began coming in. The implant remained on the market, and in November of 2009 the FDA approved another Stryker metal hip implant, the ABGII. Both models of the metal hip implants came in under the FDA 510(k) approval process which allows medical devices and drugs to gain approval if the manufacturer can prove they are substantially similar to a device or drug which has already garnered FDA approval. While in theory this process sounds reasonable, in practice, many of these drugs and devices were able to be approved based on prior devices or drugs which also had their own problems.

Problems with the 510(k) Process
In the case of the Stryker Rejuvenate, it gained FDA approval based on being substantially similar to the Wright Profemur—which has made the news because of harm to its recipients. In some cases one defective medical device or drug after another can find their way onto the market—and into the bodies of unsuspecting people who likely believe there doctor would not be able to implant a device into their body unless it were safe. Over 500,000 people in the United States alone have metal hip implants in their body despite the fact that a recent FDA panel met to discuss the merits of the metal-on-metal implant and stated that given the many problems which have surfaced on particular metal implants, there was really no reason for surgeons to continue to implant the metal devices.